Earnings release
Page 1
Press release - Regulated Information Melexis Q3 2025 results – Third quarter sales of 215.3 million EUR Intermediate declaration by the Board of Directors Ieper, Belgium – October 29th, 2025, 07.00 hrs CET CONFORM IFRS Q3 2025 Q3 2024 YOY change Q2 2025 SEQ change in k EUR (%) (%) Sales 215,287 247,858 -13% 211,589 2% Gross result 83,425 108,241 -23% 82,602 1% Gross Margin 38.8% 43.7% 39.0% EBIT 37,845 64,210 -41% 35,650 6% EBIT in % 17.6% 25.9% 16.8% EBITDA 51,397 75,986 -32% 50,086 3% EBITDA in % 23.9% 30.7% 23.7% Net result 27,528 51,152 -46% 37,805 -27% Net result per share (EPS) 0.68 1.27 0.94 CAPEX 5,319 13,901 10,714 Sales for the third quarter of 2025 were 215.3 million EUR, a decrease of 13% compared to the same quarter of the previous year and an increase of 2% compared to the previous quarter. The EUR/USD exchange rate evolution had a negative impact of 2% on sales compared to the same quarter of last year and a negative impact of 1% on sales compared to the previous quarter. The gross result was 83.4 million EUR or 38.8% of sales, a decrease of 23% compared to the same quarter of last year and an increase of 1% compared to the previous quarter. R&D expenses were 12.8% of sales, G&A was at 6.1% of sales and Selling was at 2.3% of sales. The operating result was 37.8 million EUR or 17.6% of sales, a decrease of 41% compared to the same quarter of last year and an increase of 6% compared to the previous quarter. The net result was 27.5 million EUR or 0.68 EUR per share, a decrease of 46% compared to 51.2 million EUR or 1.27 EUR per share in the third quarter of 2024 and a decrease of 27% compared to the previous quarter. 1 Melexis Financial Press Release Regulated Information
Page 2
CONFORM IFRS 9M 2025 9M 2024 YOY change in k EUR (%) Sales 625,124 735,401 -15% Gross result 241,707 323,791 -25% Gross Margin 38.7% 44.0% EBIT 102,479 192,298 -47% EBIT in % 16.4% 26.1% EBITDA 142,740 227,657 -37% EBITDA in % 22.8% 31.0% Net result 89,931 153,167 -41% Net result per share (EPS) 2.23 3.79 CAPEX 21,673 46,223 Sales for the first nine months of 2025 were 625.1 million EUR, a decrease of 15% compared to the first nine months of 2024. The EUR/USD exchange rate evolution had a negative impact of 1% on sales compared to the first nine months of 2024. The gross result was 241.7 million EUR or 38.7% of sales, a decrease of 25% compared to the same period last year. R&D expenses were 13.6% of sales, G&A was at 6.4% of sales and Selling was at 2.3% of sales. The operating result was 102.5 million EUR or 16.4% of sales, a decrease of 47% compared to 192.3 million EUR in the same nine months of 2024. The net result was 89.9 million EUR or 2.23 EUR per share, a decrease of 41% compared to 153.2 million EUR or 3.79 EUR per share in the first nine months of 2024. Outlook Melexis expects sales in the fourth quarter of 2025 to be in the range of 215 to 220 million EUR. For the full year 2025, Melexis expects sales to be in the range of 840 to 845 million EUR, with a gross profit margin around 39% and an operating margin around 16%, all taking into account a EUR/USD exchange rate of 1.17 for the remainder of the year. For the full year 2025, Melexis expects CAPEX to be around 35 million EUR (previously around 40 million EUR). 2 Melexis Financial Press Release Regulated Information
Page 3
Business update Sales of 215.3 million EUR in the third quarter of 2025 landed just above the top end of the guidance, and resulted in sales of 625.1 million EUR for the first nine months of 2025. The outperforming product lines in the third quarter were motor drivers and pressure sensors. Sales for non automotive applications represented 12% of total sales in the third quarter of 2025, while 88% of Melexis sales were for automotive applications. Melexis launched 3 new products in Q3 2025 making a total of 9 new products in the first nine months of 2025. We added a new latch for smaller yet robust motor applications such as automotive seats and windows, and an upgrade to our smart current, voltage & temperature (IVT) sensor enabling more precise temperature measurement in safety-critical applications including automotive batteries and DC fast charging. For smart industrial and consumer sectors we launched an embedded motor driver for applications such as smart fans for server cooling and smart valves. Quote from CEO Marc Biron "We delivered a third consecutive quarter of sequential improvement in our operating results. Q3 2025 sales grew thanks to good performances in the five automotive strategic growth areas targeted by Melexis and further growth outside of automotive applications. Gross margin remained stable as anticipated and the EBIT margin rose due to ongoing fixed cost control. We continued extending our product portfolio, with the number of new products designed for applications outside of automotive such as robotics this year confirming our aim to capture substantial growth in these markets. Converting our innovations into design wins drives future sales. In Q3 2025 we recorded our two largest design wins year to date, including a motor driver specifically designed for 48V architecture of EV automobiles which is increasingly in demand by our customers. Overall we are making good progress on our commercial, operational, and strategic objectives, and look forward to sharing more details at our Capital Markets Day on November 5th." 3 Melexis Financial Press Release Regulated Information
Page 4
Financial Calendar - Capital Markets Day: November 5, 2025 - Publication FY 2025 Results: February 4, 2026 (at 7 hrs CET) - Publication Q1 2026 Results: April 29, 2026 (at 7 hrs CET) - Publication Q2 2026 Results: July 29, 2026 (at 7 hrs CET) - Publication Q3 2026 Results: October 28, 2026 (at 7 hrs CET) - Publication FY 2026 Results: February 3, 2027 (at 7 hrs CET) The company’s results will be discussed in a conference call and an audio webcast on Wednesday, October 29th, 2025 at 10:30 hrs CET. To register for the conference call (possibility to ask questions) The conference call will be in English. You have to register for this conference call in advance. You can register by clicking here and filling out the requested information. After registration, you will receive the conference call number, a participant user pin, conference pin and instructions on how to join the conference call. For security purposes, all participants must register individually if they wish to join the call. To register for the audio webcast (no possibility to ask questions) You can register for the audio webcast by clicking here. For more information: Investors Investor Relations Email: investor@melexis.com Journalists Brand & Communications Email: brandcomms@melexis.com About Melexis Melexis designs, develops, and delivers edge sensor and driver solutions with a heart for people and planet. Its mission is to empower engineers to turn their ideas into applications that support the best imaginable future, one that is safe, comfortable and sustainable. Melexis specializes in powertrain, thermal management, lighting, e-brake, e-steering and battery solutions for the automotive sector. It also expands its presence in the emerging markets of sustainable world, alternative mobility, robotics, and digital health. Founded in 1989 in Belgium, Melexis has grown to employ over 2,000 people in 12 countries, delivering cutting-edge technology to customers worldwide. For more information, visit www.melexis.com or follow Melexis on LinkedIn, and YouTube. 4 Melexis Financial Press Release Regulated Information
Page 5
Disclaimer Except for those statements that report the Company's historical results, the statements being made are forward looking statements. Actual results could differ materially from those projected in the forward- looking statements. Factors which could cause actual results to differ from expectations include the following: volatility in supply and demand affecting revenues and market prices, price and availability of silicon foundry, assembly and test prices, assembly and test subcontract capacity required to meet financial targets and/or meet backlog requirements, risks and delays associated with bringing up new production capabilities or with deliveries from subcontractors, timing and market acceptance of new products, increased expenses associated with new product acceptance of new products, increased expenses associated with new product introductions of process changes, delays in developing or achieving volume production of new products, which can result in delays or failure to contribute to revenues and profits, ability of the Company to maintain its customer and vendor base and delays in and/or inability in raising additional capital. 5 Melexis Financial Press Release Regulated Information
Page 6
Condensed consolidated interim income statement CONFORM IFRS Quarter ended Quarter ended Nine months ended Nine months ended Year ended 30/9/2025 30/9/2024 30/9/2025 30/9/2024 31/12/2024 in k EUR audited Sales 215,287 247,858 625,124 735,401 932,808 Cost of sales -131,862 -139,617 -383,417 -411,611 -531,457 Gross result 83,425 108,241 241,707 323,791 401,351 R&D -27,548 -26,565 -84,784 -80,025 -110,252 G&A -13,126 -12,693 -39,899 -37,210 -51,367 Selling -4,905 -4,773 -14,544 -14,258 -19,842 Operating result (EBIT) 37,845 64,210 102,479 192,298 219,889 Financial result -3,013 -1,740 4,900 -6,470 -14,568 Result before taxes 34,832 62,471 107,379 185,827 205,321 Income taxes -7,304 -11,319 -17,448 -32,660 -33,875 Net result 27,528 51,152 89,931 153,167 171,446 Net result per share in EUR 0.68 1.27 2.23 3.79 4.24 Condensed consolidated interim statement of financial position CONFORM IFRS Nine months ended Nine months ended Year ended 30/9/2025 30/9/2024 31/12/2024 in k EUR audited Current Assets : Cash and cash equivalents 33,321 34,463 32,681 Current investments 404 231 — A/R Trade 106,768 129,788 102,246 Assets for current tax 29,201 14,683 18,889 Other current assets 106,775 42,903 55,961 Inventories 299,095 252,405 262,815 Total current assets 575,564 474,472 472,593 Non-current assets : Property, plant and equipment 199,429 208,836 211,120 Leased assets 7,875 7,185 8,801 Intangible fixed assets 1,329 1,297 1,175 Other non-current assets 102,266 172,444 163,581 Deferred tax assets 35,109 32,825 36,985 Total non-current assets 346,008 422,587 421,662 Total assets 921,571 897,059 894,255 6 Melexis Financial Press Release Regulated Information
Page 7
CONFORM IFRS Nine months ended Nine months ended Year ended 30/9/2025 30/9/2024 31/12/2024 in k EUR audited Current liabilities : Derivative financial instruments — — 228 Current portion of LT debt 12,166 5,797 Lease liabilities 936 514 2,143 A/P trade 54,490 54,939 63,203 Accrued taxes 5,905 6,326 3,220 Short-term employee benefits accruals 24,486 17,960 18,222 Other current liabilities 5,955 8,521 9,320 Deferred income 4,066 4,412 2,076 Total current liabilities 108,004 92,672 104,210 Non current liabilities : LT debt less current portion 265,779 187,609 207,525 Lease liabilities 7,073 6,779 6,714 Deferred tax liabilities 2,344 586 3,737 Other non-current liabilities 3,675 4,466 4,567 Total non current liabilities 278,871 199,439 222,544 Shareholders' equity : Shareholders' capital 565 565 565 Treasury shares -28,754 — -4,410 Legal reserve 57 57 57 Retained earnings 478,630 455,810 403,160 Current period's profit 89,931 153,167 171,446 Cumulative translation adjustment -5,732 -4,650 -3,316 Equity attributable to company owners 534,696 604,948 567,501 Non controlling interests — — — Total shareholders equity 534,696 604,948 567,501 Total liabilities, shareholders' equity and minority interests 921,571 897,059 894,255 7 Melexis Financial Press Release Regulated Information
Page 8
Condensed consolidated interim statement of cash flows CONFORM IFRS Quarter ended Quarter ended Nine months ended Nine months ended Year ended 30/9/2025 30/9/2024 30/9/2025 30/9/2024 31/12/2024 in k EUR audited Cash flow from operating activities Net income 27,528 51,152 89,931 153,167 171,446 Adjustments for : Operating activities 24,009 26,137 63,092 75,095 90,640 Depreciation and amortisation 12,980 11,275 38,557 33,813 45,639 Depreciation leased assets 572 501 1,704 1,546 2,102 Other provisions 200 -14 -892 126 54 Deferred income 994 -6 1,990 1,486 -849 Financial result 1,958 3,062 4,285 5,464 9,819 Income tax expense/income 7,304 11,319 17,448 32,660 33,875 Operating profit before working capital changes 51,537 77,289 153,023 228,262 262,086 A/R, Trade -1,940 -10,290 -4,982 -9,582 17,961 Other current assets -7,265 -18,133 -50,814 -10,474 -23,532 Other non current assets 19,103 20,419 61,315 8,790 17,652 Inventories -13,857 3,045 -41,945 -3,173 -15,335 A/P -4,584 -7,345 -8,712 -25,091 -16,828 Employee benefit liabilities 3,769 2,712 6,247 -5,750 -5,471 Other current liabilities 1,387 -528 -3,365 -4,443 -3,644 Cash generated from operations 48,150 67,169 110,767 178,539 232,890 Interest paid -2,146 -3,044 -7,008 -8,064 -10,750 Income tax paid -1,504 -11,922 -24,473 -39,365 -48,913 Cash flow from operating activities 44,500 52,204 79,286 131,110 173,227 Cash flow from investing activities Purchase of PPE and intangible assets (netted) -7,454 -13,743 -20,896 -40,870 -53,107 Interest received 3 82 118 270 357 Cash provided from investing activities -7,451 -13,660 -20,777 -40,600 -52,750 Cash flows from financing activities Proceeds/Repayment of long-and short-term debt -36,036 -42,209 64,622 2,950 28,663 Repayment leasings -544 -497 -1,626 -1,458 -2,065 Dividend payment — — -95,976 -96,960 -149,480 Acquisition own shares -1,033 -24,344 -4,410 Cash provided from financing activities -37,614 -42,707 -57,323 -95,468 -127,293 Effect of exchange rate changes on cash and cash equivalents -26 75 -545 71 148 Increase/decrease in cash and cash equivalents -590 -4,088 640 -4,886 -6,668 Cash at beginning of the period 33,912 38,551 32,681 39,349 39,349 Cash at the end of the period 33,321 34,463 33,321 34,463 32,681 8 Melexis Financial Press Release Regulated Information
Page 9
Sales per Geography Q3 2025 Q3 2024 9M 2025 9M 2024 FY 2024 APAC 61% 61% 62% 60% 60% Asia Pacific EMEA 31% 30% 29% 31% 31% Europe - Middle-East - Africa NALA 8% 9% 8% 9% 9% North America - Latin America TOTAL 100% 100% 100% 100% 100% 9 Melexis Financial Press Release Regulated Information